Abstract:MicroRNAs play a crucial role in directly reprogramming (converting) human fibroblasts into neurons. Specifically, miR-9/9* and miR-124 (miR-9/9*-124) display neurogenic and cell fate-switching activities when ectopically expressed in human fibroblasts by erasing fibroblast identity and inducing a pan-neuronal state. These converted neurons maintain the biological age of the starting fibroblasts and thus provide a human neuron-based platform to study cellular properties in aged neurons and model adult-onset neurodegenerative disorders using patient-derived cells. Furthermore, the expression of striatal-enriched transcription factors in conjunction with miR-9/9*-124 guides the identity of medium spiny neurons (MSNs), the primary targets in Huntington's disease (HD). Converted MSNs from HD patient-derived fibroblasts (HD-MSNs) can replicate HD-related phenotypes including neurodegeneration associated with age-related declines in critical cellular functions such as autophagy. Here, we review the role of microRNAs in the direct conversion of patient-derived fibroblasts into MSNs and the practical application of converted HD-MSNs as a model for studying adult-onset neuropathology in HD. We provide valuable insights into age-related, cell-intrinsic changes contributing to neurodegeneration in HD-MSNs. Ultimately, we address a comprehensive understanding of the complex molecular landscape underlying HD pathology, offering potential avenues for therapeutic application.

Author Correction: Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes

Author Correction: Reversing a model of Parkinson’s disease with in situ converted nigral neurons

Reversing a model of Parkinson's disease with in situ converted nigral neurons (vol 53, pg 863, 2020)

Author Correction: Single-cell transcriptomic analysis of Alzheimer’s disease

Correction: Corrigendum: Opportunities and challenges in modeling human brain disorders in transgenic primates

Author Correction: Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy

Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology

Author Correction: Suppression of Glioblastoma by a Drug Cocktail Reprogramming Tumor Cells into Neuronal Like Cells

Parkinson's Disease-Related Leucine-rich Repeat Kinase 2 Modulates Nuclear Morphology and Genomic Stability in Striatal Projection Neurons During Aging.

Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy

Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo

Author Correction: Humanizing the Mdx Mouse Model of DMD: the Long and the Short of It

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease

Correction to: Longitudinal transcriptomic characterization of viral genes in HSV-1 infected tree shrew trigeminal ganglia

Patient-derived neuron model: Capturing age-dependent adult-onset degenerative pathology in Huntington's disease

Author Correction: Mutations Disrupting Neuritogenesis Genes Confer Risk for Cerebral Palsy

Author Correction: Morphing Electronics Enable Neuromodulation in Growing Tissue

Author Correction: C/EBPβ Regulates Delta-Secretase Expression and Mediates Pathogenesis in Mouse Models of Alzheimer’s Disease

Author Correction: Hybrid PET/MRI enables high-spatial resolution, quantitative imaging of amyloid plaques in an Alzheimer’s disease mouse model

Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" 413-429]